Save on Epiduo® Gel

Get your Epi•Do•Over started.

Already registered? Just enter your email address to receive your offer.*

Not registered? Click here.

Important Safety Information
Indication: EPIDUO® Gel is indicated for the topical treatment of acne vulgaris in patients 9 years of age and older. Adverse Events: In controlled clinical studies, the most commonly reported adverse events (≥1%) in patients treated with EPIDUO® Gel were dry skin, contact dermatitis, application site burning, application site irritation and skin irritation. Warnings/Precautions: Patients taking EPIDUO® Gel should avoid exposure to sunlight and sunlamps and wear sunscreen when sun exposure cannot be avoided. Erythema, scaling, dryness, stinging/ burning, irritant and allergic contact dermatitis may occur with use of EPIDUO® Gel and may necessitate discontinuation.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‐800‐FDA‐1088.

*This savings is not valid for prescriptions paid for in part or full by any federal or state program, including Medicaid, Medicare, or Medigap ("Government Program"). Void where prohibited by law, taxed, or restricted. THIS OFFER IS AVAILABLE FOR A LIMITED TIME ONLY AND GALDERMA LABORATORIES RESERVES THE RIGHT TO RESCIND, REVOKE, AMEND, OR TERMINATE THIS OFFER AT ANY TIME WITHOUT NOTICE. Insured patients could pay no more than $25* for their first Epiduo® Gel prescription, $15 for their first refill and $10 for additional refills (for one tube or pump, after primary insurance and the Epiduo Gel Savings Card). Payment will depend on actual insurance coverage.

©2013 Galderma Laboratories, L.P. United States, All Rights Reserved. All trademarks are the property of their respective owners. This site intended for U.S. audiences only. Information in this website is not intended as medical advice. Talk to your doctor about medical concerns.

Important Safety Information

Indication: EPIDUO® Gel is indicated for the topical treatment of acne vulgaris in patients 9 years of age and older. Adverse Events: In controlled clinical studies, the most commonly reported adverse events (≥1%) in patients treated with EPIDUO® Gel were dry skin, contact dermatitis, application site burning, application site irritation and skin irritation. Warnings/Precautions: Patients taking EPIDUO® Gel should avoid exposure to sunlight and sunlamps and wear sunscreen when sun exposure cannot be avoided. Erythema, scaling, dryness, stinging/ burning, irritant and allergic contact dermatitis may occur with use of EPIDUO® Gel and may necessitate discontinuation.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Share the news

Send me a copy of this email

See Privacy Policy >